Dr. Holly Elizabeth Kanavy, DO

Dr. Kanavy practices at Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein.

Dr. Kanavy's NPI, 1386965408, was assigned on June 14, 2010. Dr. Kanavy holds New York license 250669.

Dr. Kanavy's primary practice is Montefiore Einstein Hospital-Moses Campus, at 111 East 210th Street, Bronx, NY 10467 in Bronx County. The practice phone is (718) 920-4321.

Dr. Kanavy's primary practice is Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Dr. Kanavy to 1 more school health center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kanavy practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Kanavy's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Kanavy is licensed in New York.

CMS data shows 404 Medicare services from Dr. Kanavy across 5 procedure codes in 2024, for 195 Medicare patients. Medicare paid $23,229 for them.

CMS counts 195 Medicare patients who saw Dr. Kanavy in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 45% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kanavy's median patient age at 56, with 68% women.

In 2024, Dr. Kanavy wrote 2,220 Medicare Part D claims for 371 patients. 85% of them were for generic drugs. CMS names the drug for 2,046 of them, across 38 drugs with 11 or more claims each, at $1,063,584 in total drug cost. In 2023, CMS named 2,291 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kanavy for performance year 2024, reported as part of a group. CMS lists Dr. Kanavy as offering telehealth. CMS counts 26 procedures of removal of skin lesions by Dr. Kanavy, more than 67% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Kanavy, published from 2011 to 2022. Dr. Kanavy's most frequent co-authors are Maria Ajaimy, MD, Jennifer Dawn Bahner, MD and Shadi Damanpour, MD.

Dmand AI links Dr. Kanavy to 4 clinical trials. Conditions studied include Eczema, Dermatitis, Atopic and Alopecia Areata. Eli Lilly and Company sponsors the most, 3.

CMS Open Payments shows 548 general payments to Dr. Kanavy from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 59% of the total. Novartis Pharmaceuticals Corporation paid the most, $18,137. It also lists 1 research payment totaling $695 in 2016.